Last $82.15 USD
Change Today -1.02 / -1.23%
Volume 1.0K
SHPGF On Other Exchanges
Symbol
Exchange
SHPGF is not on other exchanges.
As of 8:10 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

Transactions by SHIRE PLC (SHPGF) in the last 6 months

Announced 07/23/14
ArmaGen Technologies, Inc.
Private Placement

ArmaGen Technologies, Inc. announced that it will receive funding from new investor Shire plc on July 23, 2014. The company will receive upfront payment of $15 million in cash and equity, an additional equity investment in the transaction.


SHPGF's price was unchanged after the transaction was announced on 07/23/14.
Investor / Buyer
Shire plc
 
Announced 06/19/14
31.74B for Shire plc
Merger/Acquisition

AbbVie Inc. (NYSE:ABBV) made an indicative offer to acquire Shire plc (LSE:SHP) for £23.8 billion on May 5, 2014. Under the terms, AbbVie will pay £16.23 in cash and issue its 0.768 share for each share of Shire. AbbVie made a revised offer to acquire Shire for £24.4 billion on May 13, 2014. Under the terms, AbbVie will pay £17.13 in cash and issue its 0.768 share for each share of Shire. AbbVie made a revised offer to acquire Shire for £26.9 billion on May 30, 2014. ...
Read More


SHPGF's price was unchanged after the transaction was announced on 06/19/14.
 
Announced 05/12/14
295.00M for Lumena Pharmaceuticals Inc.
Merger/Acquisition

Shire plc (LSE:SHP) acquired Lumena Pharmaceuticals, Inc. from Pappas Ventures, RiverVest Venture Partners, LLC, Alta Partners LP, New Enterprise Associates, Adage Capital Management, L.P. and RA Capital Management, LLC for $260 million in cash and earnout payments on May 12, 2014. Shire will pay $260 million in cash, net cash payment at cloisng and near-term contingent milestone payments related to ongoing clinical trials. Shire does not expect the acquisition of Lumena ...
Read More


SHPGF's price was unchanged after the transaction was announced on 05/12/14.
Investor / Buyer
Shire plc
Creditor / Lender
Adage Capital Management, L.P.
Alta Partners LP
New Enterprise Associates
Pappas Ventures
RA Capital Management, LLC
RiverVest Venture Partners, LLC
Financial Advisor
Citigroup Inc.
 
Announced 05/1/14
75.00M for Fibrotech Therapeutics Pty Ltd.
Merger/Acquisition

Shire plc (LSE:SHP) entered into a definitive agreement to acquire Fibrotech Therapeutics Pty Ltd. from MRCF IIF, L.P, Brandon Biosciences Fund 1 IIF Partnership, L.P. and MRCF IIF, L.P., funds of Brandon Capital Partners, Universities Innovation Investment Trust, a fund of Uniseed Pty Limited, and others for $75 million on May 1, 2014. The consideration includes upfront payment of $75 million and certain contingent payments based on the achievement of development and ...
Read More


SHPGF's price was unchanged after the transaction was announced on 05/1/14.
Investor / Buyer
Shire plc
Creditor / Lender
Brandon Biosciences Fund 1 IIF Partnership, L.P.
Brandon Capital Partners
MRCF IIF, L.P.
Uniseed Pty Limited
Universities Innovation Investment Trust
 
Announced 04/29/14
Shire plc
Buyback

Shire plc (LSE:SHP) announces a share repurchase program. Under the program, the company will repurchase up to 58,896,580 ordinary shares, representing 10% of the issued share capital. The minimum price, which may be paid for an ordinary share is 5 pence. The maximum price, which may be paid for an ordinary share shall be the higher of an amount equal to 105% of the average of the middle market quotations for the company’s ordinary shares as taken from the London Stock ...
Read More


SHPGF's price was unchanged after the transaction was announced on 04/29/14.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHPGF:US $82.15 USD -1.02

SHPGF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $214.26 USD -1.29
Allergan Inc/United States $165.86 USD -6.31
Celgene Corp $87.15 USD -1.19
CSL Ltd A$65.99 AUD -1.81
Valeant Pharmaceuticals International Inc C$127.83 CAD -9.59
View Industry Companies
 

Industry Analysis

SHPGF

Industry Average

Valuation SHPGF Industry Range
Price/Earnings 30.3x
Price/Sales 9.1x
Price/Book 8.0x
Price/Cash Flow 44.9x
TEV/Sales 9.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHIRE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.